Regeneron Pharmaceuticals has announced that its antibody drug REGEN-COV is 81.6% effective at preventing Covid Infection in uninfected people who are at risk. The company also said that the drug is effective in reducing the severity of infection in people with COVID who are not hospitalized.

The post Regeneron Says REGEN-COV Reduces Risk of COVID Infection By 81.6% appeared first on Latest Health & Medical News – Myhealthyclick.com.